IO for Unresectable Stage 3 NSCLC: Does Durvalumab Help Patients? What Are the Leading Treatment Options for Patients With Low / Negative PD-L1 Expression?
By
GRACE
FEATURING
Millie Das
By
GRACE
FEATURING
Millie Das
67 views
January 21, 2021
Comments 0
Login to view comments.
Click here to Login